Cite
HARVARD Citation
Randhawa, M. et al. (2019). The National Radium-223 Dichloride Audit Group: Data from Patients in 17 UK Oncology Centres with Metastatic Castrate-resistant Prostate Cancer Treated with Radium-223 Dichloride. Clinical oncology. 31 (2), pp. e24-. [Online].